losartan has been researched along with Myocarditis in 7 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether losartan has protective effects in mice with chronic viral myocarditis induced by coxsackievirus B3 (CVB3)." | 7.79 | Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. ( Li, JN; Miao, SK; Wu, YY; Xia, HH; Zhang, SL; Zhang, YY; Zhong, J; Zhou, LM, 2013) |
| "Losartan, a recently developed nonpeptide angiotensin II (AII) receptor antagonist, was orally administered for 14 days to mice with viral myocarditis, beginning 7 days after encephalomyocarditis virus inoculation." | 7.69 | Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. ( Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T, 1995) |
| "To investigate whether losartan has protective effects in mice with chronic viral myocarditis induced by coxsackievirus B3 (CVB3)." | 3.79 | Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. ( Li, JN; Miao, SK; Wu, YY; Xia, HH; Zhang, SL; Zhang, YY; Zhong, J; Zhou, LM, 2013) |
| " Treatment with losartan significantly attenuated TAC-induced cardiac hypertrophy, in parallel with decreased expression of RANKL, TNF-α, IL-1α, and IL-1β." | 3.78 | Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation. ( Abel, ED; Ahn, J; Kim, HS; Kim, J; Lee, SH; Lee, WS; Min, JK; Ock, S; Oh, GT; Oh, JG; Park, H; Park, WJ; Rho, J; Son, JW; Yang, DK, 2012) |
| "The angiotensin converting enzyme inhibitor captopril prevents myosin-induced experimental autoimmune myocarditis." | 3.74 | Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis. ( Bahk, TJ; Daniels, MD; Engman, DM; Leon, JS; Wang, K, 2008) |
| "Animals were divided into three groups: myocarditis, myocarditis intervened by Losartan, and normal control." | 3.70 | [Preventional intervention of myocardial interstitial fibrosis in murine myocardium with acute myocarditis]. ( Cheng, X; Jing, Z; Yang, Y, 1998) |
| "Losartan, a recently developed nonpeptide angiotensin II (AII) receptor antagonist, was orally administered for 14 days to mice with viral myocarditis, beginning 7 days after encephalomyocarditis virus inoculation." | 3.69 | Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. ( Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T, 1995) |
| "Coxiella burnetii myocarditis is a rare but severe clinical form of acute Q fever." | 1.31 | [Acute myocardial failure in a young man: Q-fever myocarditis]. ( Climent, V; López, I; Manso, MI; Murcia, J; Reus, S; Tello, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Zijll Langhout, M | 1 |
| Wolters, M | 1 |
| Horvath, KM | 1 |
| Thiesbrummel, H | 1 |
| Smits, P | 1 |
| van Bolhuis, H | 1 |
| van der Hulst, V | 1 |
| Riezebos, R | 1 |
| Zhang, YY | 1 |
| Li, JN | 1 |
| Xia, HH | 1 |
| Zhang, SL | 1 |
| Zhong, J | 1 |
| Wu, YY | 1 |
| Miao, SK | 1 |
| Zhou, LM | 1 |
| Ock, S | 1 |
| Ahn, J | 1 |
| Lee, SH | 1 |
| Park, H | 1 |
| Son, JW | 1 |
| Oh, JG | 1 |
| Yang, DK | 1 |
| Lee, WS | 1 |
| Kim, HS | 1 |
| Rho, J | 1 |
| Oh, GT | 1 |
| Abel, ED | 1 |
| Park, WJ | 1 |
| Min, JK | 1 |
| Kim, J | 1 |
| Murcia, J | 1 |
| Reus, S | 1 |
| Climent, V | 1 |
| Manso, MI | 1 |
| López, I | 1 |
| Tello, A | 1 |
| Bahk, TJ | 1 |
| Daniels, MD | 1 |
| Leon, JS | 1 |
| Wang, K | 1 |
| Engman, DM | 1 |
| Araki, M | 1 |
| Kanda, T | 1 |
| Imai, S | 1 |
| Suzuki, T | 1 |
| Murata, K | 1 |
| Kobayashi, I | 1 |
| Jing, Z | 1 |
| Cheng, X | 1 |
| Yang, Y | 1 |
7 other studies available for losartan and Myocarditis
| Article | Year |
|---|---|
Clinical signs, diagnostics and successful treatment of a myocarditis in an adult chimpanzee (Pan troglodytes).
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Ape Diseases; Carbazoles; Carvedilol; | 2017 |
Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cardiotonic Agents; Cells, Cultured; Coxsackievirus Inf | 2013 |
Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antibodies, Monoclonal; Antibodi | 2012 |
[Acute myocardial failure in a young man: Q-fever myocarditis].
Topics: Acute Disease; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibodies, Bacterial; Cardiomy | 2002 |
Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoanti | 2008 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihyperten | 1995 |
[Preventional intervention of myocardial interstitial fibrosis in murine myocardium with acute myocarditis].
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Fibrosis; Losartan; Male; Mice; Mice, Inbr | 1998 |